SCHEMBL20848640

SCHEMBL20848640

CC1(C(=O)Oc2ccc(C(C)(c3ccc(OC(=O)C4(C)COC(=O)OC4)cc3)c3ccc(OC(=O)C4(C)COC(=O)OC4)cc3)cc2)COC(=O)OC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.35
POLB P06746 3/20 0.35
TDP1 Q9NUW8 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ELANE P08246 6/20 0.33
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
NPSR1 Q6W5P4 2/20 0.31
GAA P10253 1/20 0.31
XBP1 P17861 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
S1PR1 P21453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20848344 0.89 POLB (0.40) MAPTRAB9AHTTSMN1; SMN2L3MBTL1
SCHEMBL20848342 0.85 POLB (0.38) MAPTRAB9ANPC1HTTSMN1; SMN2
SCHEMBL17589271 0.82 L3MBTL1 (0.50) MAPTSMN1; SMN2L3MBTL1POLBTDP1
SCHEMBL20848641 0.75 LIPE (0.35) MAPTL3MBTL1POLBMEN1KMT2A
SCHEMBL8587060 0.73 MAPT (0.51) MAPTRAB9ANPC1HTTSMN1; SMN2
SCHEMBL18257757 0.73 LIPE (0.36) MAPTMEN1KMT2AGAA
SCHEMBL18257751 0.72 GAA (0.36) MAPTRAB9ANPC1HTTSMN1; SMN2
SCHEMBL10202259 0.72 GAA (0.34) MAPTSMN1; SMN2TP53GAA
SCHEMBL24885613 0.71 NAAA (0.44) MAPTRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL832774 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190091338-A1 MIKTO-ARM STAR POLYMERS FOR DELIVERY OF THERAPEUTIC AGENTS INTERNATIONAL BUSINESS MACHINES CORPORATION 2019-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190091338-A1 MIKTO-ARM STAR POLYMERS FOR DELIVERY OF THERAPEUTIC AGENTS COQ8A, COQ8B, STARD7 MAPT 1748/4885RAB9A 3578/4885NPC1 2877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.